Connect with us


Dr. Jerry Tenenbaum: Patients Upset – Poor Treatment Cited


on Why are Dr.Tenenbaum’s patients so upset? Why is it that a majority of them refuse to recommend him to others? What is going on? While a large number of his patients are not ready to pay him another visit, on the other hand, a handful of them are just full of praises for him. There seem to be two extremes, though unequally divided, the bulk being against him.

For those who don’t know Dr. Jerry Tenenbaum, a certain website cites him to be a professor of Medicine at the University of Toronto, the Director of International Medical Graduate Program of Ontario and a Consultant of Rheumatology and Internal Medicine at Mount Sinai Hospital. Now let’s take a closer look at what he has done wrong to deserve such an outrage.

His behaviour seems to be a major problem according to his patients. They describe him as “rude” and “hurried”. They feel that he is a bit too harsh and direct. Some also expressed problems with his diagnosis and examination techniques. The patients were not very satisfied with his treatment and a few experienced a worsening of their maladies. One of the patients complained,

“I felt he rushed through too quickly and he didn’t seem too compassionate.”

Some patients, although loathing his bedside manner, were quite appreciative of his specialty and achievements. According to them, his expertise made up for his offensively impolite behaviour. Out of the many, one went on to say,

“I have found him to be extremely thorough. He seems genuinely concerned about eliminating pain/discomfort. He is some what brisk but takes the time to answer any questions that are asked. I would not hesitate to recommend him to friends.”

We can clearly see one thing, whetherpatients in his favour or the ones at odds with him, every one of them agrees that he has a certain level of audacity that is unlikable. Some have outright questioned his competence. And herein lies one of my concerns. With two contrasting opinions, we cannot determine Dr. Tenenbaum’s brilliance. Behaviour should not be used as a determinant, and the common man cannot know better than a doctor. You need to be one to know one.I suggest that you should consult more than one doctor whenever seeking treatment.

The issue at hand- of being rude and brisk- brings forth the question of ethics. The majority expects the doctor’s approach to be considerate. Dr. Tenenbaum appears to be acting in defiance of his patients’ expectations. And it is very common to experience disappointment when someone does that. Another complain was too many medical tests, which makes one wonder if he is only after monetary profit? It is always advisable to know about your doctor’s reputation.

Is being polite a part of the doctor’s job description? Typical work activities require doctors to be caring. So, does caring mean being kind and courteous all the time? Well, Dr. Tenenbaum’s bearing seems to disagree. Nevertheless, his seemingly unethical conduct is highly questionable. To me, this seems to be the most probable reason for the unhappiness of patients. As for destroyed lives, one is unforgivable.


Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Hundreds of Indonesian healthcare workers contract COVID-19 despite vaccination, dozens hospitalised



JAKARTA: More than 350 Indonesian doctors and healthcare workers have contracted COVID-19 despite being vaccinated with Sinovac and dozens have been hospitalised, officials said, as concerns rise about the efficacy of some vaccines against more virulent virus strains.

Most of the doctors were asymptomatic and self-isolating at home, said Badai Ismoyo, head of the Kudus district health office in Central Java, but dozens were in hospital with high fevers and declining oxygen saturation levels.

Kudus is battling an outbreak believed to be driven by the more transmissible Delta variant which has pushed bed occupancy rates above 90 per cent in the district.

Designated as a priority group, Indonesian healthcare workers were among the first to be vaccinated when the inoculation drive started in January.

Almost all have received the COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac, according to the Indonesian Medical Association.

While the number of Indonesian healthcare workers dying from COVID-19 has decreased significantly – dropping from 158 deaths this January to 13 this May, according to data initiative group LaporCOVID-19 – public health experts say the Java hospitalisations are cause for concern.

“The data shows they have the Delta variant so it is no surprise that the breakthrough infection is higher than before because as we know the majority of healthcare workers in Indonesia got Sinovac, and we still don’t know yet how effective it is in the real world against the Delta variant,” said Dicky Budiman, an epidemiologist from Australia’s Griffith University.

Continue Reading


China’s Covid-19 vaccine flops in Singapore too



New Delhi: In a major setback to Chinas Covid vaccines, Singapore is not counting its citizens who received Sinovac Biotech shots as being vaccinated against Covid-19 due to lack of data to show that the doses are effective against coronavirus, especially the Delta strain.

“We don’t really have a medical or scientific basis or have the data now to establish how effective Sinovac is in terms of infection and severe illnesses on Delta,” local media cited health minister Ong Ye Kung as saying at a press conference on Wednesday.

The decision comes close on the heels of serious doubts arising over Chinese vaccines in Indonesia as those who have received the shots are also contracting Covid-19 and infections are surging in the country.

The Delta variant is currently the dominant strain of Covid-19 in Singapore and was identified in the city state in May. Only people who have received the Moderna and Pfizer shots, are being considered as vaccinated in the official records.

Singapore had allowed some private clinics to offer the Sinovac shot, CoronaVac, from mid-June. Around 17,000 people are reported to have received one dose of CoronaVac.

Local media had also reported Singapore’s director of medical services saying last month that evidence from other countries showed people who had taken CoronaVac were still getting infected.

Most of the vaccines being used by Indonesia have also come from China’s Sinovac Biotech. Some health workers inoculated with Sinovac jabs have been hospitalized due to Covid-19. A few have even died despite being fully immunized, according to a report in Nikkei Asia.

The Indonesian Doctors Association says that of the 14 doctors who died from the virus between February and May, ten had been fully vaccinated with Sinovac, while the rest had been given one dose.

Although there is a serious problem with Chinese vaccines due to inadequate data to show their efficacy, some countries are being forced to opt for them because of the cute shortage of vaccines worldwide amid the devastating pandemic.

Continue Reading


102 people qualify for S$451,000 in Covid-19 vaccine injury financial aid to date: Ong Ye Kung



SINGAPORE — The authorities have approved S$451,000 worth of financial aid to people who had suffered serious side effects from Covid-19 vaccines in Singapore, Health Minister Ong Ye Kung said on Tuesday (July 6).

The payments have either been paid out or are being processed to 102 applicants under the Vaccine Injury Financial Assistance Programme (Vifap) introduced by the Government in January.

They were among a total of 292 applicants who had submitted a complete Vifap application as of June 25, Mr Ong said.

Of these, 159 did not meet the eligibility criteria and 31 applications are waiting to be reviewed by an independent clinical panel or pending more medical information from the applicant’s doctor.

Mr Ong was responding in a written answer to a parliamentary question filed by Ms He Ting Ru, Member of Parliament for Sengkang Group Representation Constituency, who had asked about the applications made and payments approved under the programme.

TODAY has asked the Ministry of Health (MOH) for details of these approved payouts.

Vifap provides three tiers of support to people assessed to be adversely affected by their Covid-19 inoculation.

The first is a one-time payout of S$2,000 for patients who need hospitalisation and medical intervention and who later recover.

The second is a payout of up to S$10,000 that will be given to those who were hospitalised and required care in a high dependency or intensive care unit, but later recover from the side effects caused by the vaccine.

Continue Reading